TY  - JOUR

T1  - First-line avelumab plus chemotherapy in patients with advanced solid tumors: results from the phase Ib/II JAVELIN chemotherapy medley study

JO  - Cancer Research Communications

UR  - https://eprints.whiterose.ac.uk/id/eprint/215625

PY  - 2024/06/28

AU  - Wheatley DA

AU  - Berardi R

AU  - Climent Duran MA

AU  - Tomiak A

AU  - Greystoke AP

AU  - Joshua AM

AU  - Arkenau H-T

AU  - Géczi L

AU  - Corbacho JG

AU  - Paz-Ares LG

AU  - Hussain SA et al

ED  - 

DO  - DOI: 10.1158/2767-9764.crc-23-0459

PB  - American Association for Cancer Research (AACR)

VL  - 4

IS  - 6

SP  - 1609

EP  - 1619

Y2  - 2025/12/05

ER  -